Globus Medical, Inc. (GMED)

Compare

75.50

+2.11

+(2.88%)

At close: 4:00:02 PM EDT

74.22

-1.28

(-1.70%)

After hours: 5:17:13 PM EDT

Despite the downward trend in earnings at Globus Medical (NYSE:GMED) the stock grows 7.0%, bringing five-year gains to 80%

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...

Simply Wall St. 7 days ago

GMED
+2.88%
1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 9.2%. This performance was worse than the S&P 500’s 1.8% loss.

StockStory 12 days ago

ALGN

GMED
+2.88%
GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

Globus Medical's robust musculoskeletal offerings and synergies from the NuVasive merger are fueling its stock gains.

Zacks 12 days ago

GMED
+2.88%
VCYT

BSX
Should You Hold Globus Medical Stock in Your Portfolio Now?

GMED stays on investors' radar due to its high NuVasive-merger synergies and solid Musculoskeletal prospects.

Zacks 14 days ago

GMED
+2.88%
New Product Launches Benefit GMED Stock Amid Macro Issues

Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

Zacks 15 days ago

GMED
+2.88%
RMD
Globus Medical Expands Anterior Spine Portfolio With Two New Offerings

GMED announces the commercial launch of COHERE ALIF Spacer and Modulus ALIF Blades.

Zacks 19 days ago

GMED
+2.88%
MDT

SYK
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer: The first Porous PEEK™ interbody spacer for anterior lumbar interbody fusion (ALIF) surgery, andModulus™ ALIF Blades: An extension of the market-leading Modulus™ ALIF interbody spacer system. The COHERE ™ ALIF Spacer is the latest addition to Globus Medical’s Advanced Materials Science™ (AMS) implant portfo

GlobeNewswire 22 days ago

GMED
+2.88%
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers.

StockStory 22 days ago

GMED
+2.88%
INSP

HAE
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) in San Diego, Calif., from March 10-14, 2025. Join Globus at booth #2517 to learn about the comprehensive Globus Medical product portfolio across Spine, Trauma, and Joint Reconstruction procedures; Enabling Technology; Power Tools; and Regenerative Biom

GlobeNewswire 27 days ago

GMED
+2.88%
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 4:30 pm Pacific TimeAUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT. Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” sectio

GlobeNewswire 27 days ago

GMED
+2.88%
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?

Investors need to pay close attention to Globus Medical (GMED) stock based on the movements in the options market lately.

Zacks 28 days ago

GMED
+2.88%
Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture

Investors were disappointed with the weak earnings posted by Globus Medical, Inc. ( NYSE:GMED ). However, our analysis...

Simply Wall St. 28 days ago

GMED
+2.88%
Is Globus Medical, Inc. (GMED) the Best Medical Technology Stock to Buy According to Analysts?

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where Globus Medical, Inc. (NYSE:GMED) stands against the other medical technology stocks. Growth and Drivers of the Global MedTech Market The MedTech sector is crucial in healthcare, which […]

Insider Monkey 28 days ago

GMED
+2.88%
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its fourth-quarter and full-year 2024 financial results.

PR Newswire 29 days ago

NVRO

GMED
+2.88%
1 Mid-Cap Stock to Target This Week and 2 to Avoid

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

StockStory 29 days ago

FFIV

SNA

GMED
+2.88%
Is Globus Medical, Inc. (NYSE:GMED) Trading At A 32% Discount?

Key Insights Globus Medical's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Globus Medical's...

Simply Wall St. last month

GMED
+2.88%
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks last month

GMED
+2.88%
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips

GMED's fourth-quarter 2024 performance reflects strong synergies from the NuVasive merger.

Zacks last month

GMED
+2.88%
RMD

CAH
Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

Globus Medical Inc (GMED) reports a 61% annual revenue increase and outlines strategic plans following the Nevro acquisition.

GuruFocus.com last month

GMED
+2.88%
NVRO
Globus Medical (GMED) Q4 2024 Earnings Call Transcript

GMED earnings call for the period ending December 31, 2024.

Motley Fool last month

GMED
+2.88%

Performance Overview

Return	GMED	S&P 500 (^GSPC)
YTD	-8.72%	-3.58%
1-Year	+45.70%	+8.94%
3-Year	-0.88%	+24.75%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Globus Medical, Inc. (GMED)

Despite the downward trend in earnings at Globus Medical (NYSE:GMED) the stock grows 7.0%, bringing five-year gains to 80%

1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

Should You Hold Globus Medical Stock in Your Portfolio Now?

New Product Launches Benefit GMED Stock Amid Macro Issues

Globus Medical Expands Anterior Spine Portfolio With Two New Offerings

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?

Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture

Is Globus Medical, Inc. (GMED) the Best Medical Technology Stock to Buy According to Analysts?

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

1 Mid-Cap Stock to Target This Week and 2 to Avoid

Is Globus Medical, Inc. (NYSE:GMED) Trading At A 32% Discount?

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips

Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

Globus Medical (GMED) Q4 2024 Earnings Call Transcript

Performance Overview